EUVIMEDEUVIMED entdecken
Fallbericht

Mucosal Bleeding in a Newborn With Low Factor VIII Activity: An Unusual Combination of Type 2A and Type 2N von Willebrand Disease

Gianna G Valenti, A P Miller, A C Weyand, K D Friedman, M Chitlur

Haemophilia · 2026-05 · 32 (3) · 779-784

DOI: 10.1111/hae.70245 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Haemophilia, online erschienen am 12.04.2026. Verfasst von Gianna G Valenti und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Hematology/Oncology, Children's Hospital of Michigan, Central Michigan University, Detroit, Michigan, USA. Hauptthemen laut MEDLINE: von Willebrand Disease, Type 2, Factor VIII, Hemorrhage. Die Arbeit nennt 38 Literaturangaben. Gefördert von: None.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

This case report describes a newborn male presenting with mucosal bleeding and low Factor VIII activity, ultimately diagnosed with a rare compound heterozygous form of von Willebrand Disease (VWD) involving both type 2A and type 2N variants through previously unknown pathogenic mutations.

Methods

A single patient case report.

Results

Genetic testing revealed two heterozygous variants in the VWF gene c.2422_2424del [p.Cys808del] and c.2999A > G [p.Asp1000Gly]), previously described as variants of unknown significance, inherited in trans from each parent, resulting in a severe VWD phenotype marked by significantly reduced von Willebrand Factor (VWF) antigen, GpIbM activity, collagen binding, and FVIII activity. Laboratory analysis revealed abnormal VWF multimer patterns distinct from those of classic type 2A or 2N VWD. The patient was managed with emicizumab prophylaxis and intermittent antifibrinolytics.

Conclusion

This case highlights the diagnostic and therapeutic challenges of atypical VWD presentations influenced by novel genetic variants. These findings underscore the importance of comprehensive clinical, laboratory, and genetic evaluation in complex bleeding disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

von Willebrand Disease, Type 2Factor VIIIHemorrhageHumansMaleInfant, Newbornvon Willebrand FactorMutationHeterozygote

Stichwörter der Autor:innen

compound heterozygositypediatric bleeding disordervon Willebrand diseasevon Willebrand disease Type 2von Willebrand factor

Substanzen

Factor VIIIvon Willebrand Factor

Autor:innen und Institutionen

  • Department of Pediatrics, Division of Hematology/Oncology, Children's Hospital of Michigan, Central Michigan University, Detroit, Michigan, USA.
  • Diagnostic Laboratories, Versiti/Blood Center of Wisconsin, Milwaukee, Wisconsin, USA.
  • Division of Pediatric Hematology Oncology, University of Michigan Medical School, Ann Arbor, Michigan, USA.
  • Medical Sciences Institute, Versiti/Blood Center of Wisconsin, and Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.

Förderung

  • None

Zitieren

APA

Valenti, G. G., Miller, A. P., Weyand, A. C., Friedman, K. D., & Chitlur, M. (2026). Mucosal Bleeding in a Newborn With Low Factor VIII Activity: An Unusual Combination of Type 2A and Type 2N von Willebrand Disease. Haemophilia, 32(3), 779-784. https://doi.org/10.1111/hae.70245

Vancouver

Valenti GG, Miller AP, Weyand AC, Friedman KD, Chitlur M. Mucosal Bleeding in a Newborn With Low Factor VIII Activity: An Unusual Combination of Type 2A and Type 2N von Willebrand Disease. Haemophilia. 2026;32(3):779-784. doi:10.1111/hae.70245

BibTeX
@article{Valenti2026,
  author = {Valenti, Gianna G and Miller, A P and Weyand, A C and Friedman, K D and Chitlur, M},
  title = {Mucosal Bleeding in a Newborn With Low Factor VIII Activity: An Unusual Combination of Type 2A and Type 2N von Willebrand Disease},
  journal = {Haemophilia},
  year = {2026},
  volume = {32},
  number = {3},
  pages = {779--784},
  doi = {10.1111/hae.70245}
}
Kostenlos starten →